ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1562	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	cancer treatment 0.321266 high-dose radiation therapy 0.323579 centimeters 0.269921 cancer spreads 0.270417 malignant tumor cells 0.281954 body 0.305644 chemotherapy 0.290118 PDQ cancer information 0.346817 stage III hypopharyngeal 0.274417 clinical trial search 0.347149 clinical trials 0.698171 hypopharynx 0.280224 cancer information summary 0.319294 metastatic hypopharyngeal cancer 0.310093 clinical trial 0.551798 Recurrent hypopharyngeal cancer 0.306668 patients 0.317052 stage IV hypopharyngeal 0.274937 nearby soft tissue 0.271159 treatment clinical trial 0.275593 NCI PDQ cancer 0.283768 radiation therapy 0.705932 Treatment Editorial Board 0.281401 General information 0.289657 hypopharyngeal cancer 0.722179	general cancer information 0.275426 treatment 0.442202 new cancer treatments 0.272872 NCI-supported cancer 0.296123 cancer cells 0.361641 Cancer Information Service 0.276024 patient 0.26688 lymph nodes 0.350794 treatment clinical trials 0.300384 National Cancer Institute 0.364736 swollen lymph nodes 0.277694 new treatment 0.302418 External radiation therapy 0.314938 neck 0.309398 cancer research process 0.269057 cancer clinical trials 0.358746 stage 0.310003 neck cancer 0.286172 lymph node 0.322344 cancer information summaries 0.27414 comprehensive cancer information 0.274558 cancer 0.901171 standard treatment 0.274055 Hypopharyngeal Cancer Treatment 0.314822	CLICK HERE
1653	National Cancer Institute	Html	en	Cancer Genetics Overview (PDQ®)–Health Professional Version	Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online.	risk assessment 0.737084 germline genetic testing 0.616915 pathogenic germline variants 0.607786 genetics cancer risk 0.586595 germline testing 0.54014 individual PDQ summaries 0.545357 common genetic variants 0.594544 Founder pathogenic variants 0.555775 Cancer Genetics Risk 0.634713 tumor sequencing 0.540563 cancer risk counseling 0.587676 genetic risk 0.584149 health care providers 0.553143 genetic risk assessment 0.574763 family members 0.586643 pathogenic variant 0.712171 cancer predisposition genes 0.581734 cancer risk assessment 0.656292 BRCA1/BRCA2 pathogenic variants 0.580746 rare genetic variants 0.585466 familial cancer risk 0.606217 germline pathogenic variant 0.590911 specific pathogenic variant 0.581389 genetic cancer susceptibility 0.617626 genetic sequence testing 0.55336	breast cancer panel 0.575181 genetic counseling 0.75599 certain pathogenic variants 0.569596 cancer susceptibility genes 0.662603 multigene testing 0.554102 pathogenic variants 0.772898 term pathogenic variant 0.577821 genetic information 0.615701 predisposition genetic testing 0.569525 health care 0.629277 actionable genetic variants 0.56222 cancer susceptibility 0.729483 multigene tests 0.585492 Cancer genetic counseling 0.65952 breast cancer 0.623534 cancer predisposition multigene 0.547293 cancer susceptibility gene 0.552935 well-characterized cancer susceptibility 0.539905 genetic variants 0.628939 prostate cancer 0.563348 genetic testing 0.723596 family history 0.559221 cancer risk 0.746235 cancer 0.908258	CLICK HERE
1664	National Cancer Institute	Html	en	Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors	cancer treatment 0.542006 metastatic brain tumors 0.391418 ongoing clinical trials 0.389415 PDQ cancer information 0.511527 tumor suppressor genes 0.452709 clinical trial search 0.399694 brain tumors 0.444671 CNS atypical teratoid/rhabdoid 0.388691 clinical trials 0.847224 Pediatric Treatment Editorial 0.416481 Teratoid/Rhabdoid Tumor Treatment 0.445097 cancer information summary 0.463674 clinical trial 0.521041 cancer cells 0.510172 stem cell transplant 0.396934 patients 0.411179 primary brain tumors 0.3918 treatment clinical trial 0.409064 NCI PDQ cancer 0.42324 radiation therapy 0.555658 Treatment Editorial Board 0.420841 Cord Tumors Treatment 0.414346 late effects 0.393798 treatment 0.689522 new cancer treatments 0.395428	PDQ treatment summary 0.447943 childhood brain 0.385451 Cancer Information Service 0.399251 specific cancer cells 0.397642 PDQ Pediatric Treatment 0.40786 treatment clinical trials 0.444124 National Cancer Institute 0.458723 spinal cord 0.616147 tumor cells 0.437516 effects cancer treatment 0.421518 new treatment 0.427513 childhood cancer information 0.400212 External radiation therapy 0.395094 brain tumor 0.405279 brain 0.467984 atypical teratoid/rhabdoid tumor 0.982554 PDQ summary 0.439127 cancer clinical trials 0.434177 cancer information summaries 0.39809 comprehensive cancer information 0.397631 cancer 0.740574 appropriate cancer treatment 0.419383 standard treatment 0.391688 fast-growing tumor 0.388774	CLICK HERE
1883	National Cancer Institute	Html	es	Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.	cell tumor protocols 0.408279 germinativas malignas localización 0.405353 células germinativas seminomatosos.Seminoma 0.410393 cell tumor combined 0.407867 germ cell tumours 0.412186 Perlman EJ 0.405253 Calaminus G 0.412513 Cell Cancer Collaborative 0.406794 cell tumors from 0.406747 Göbel U 0.406021 Cancer Group 0.42074 cell tumor studies 0.407558 pediatric oncology 0.41388 células germinativas mixtos 0.417539 International Germ Cell 0.417008 Children's Oncology Group 0.409014 mediastinal germ 0.406328 cell tumor study 0.408368 <2 cm 0.405406 Metástasis peritoneales macroscópicas 0.405941 germ cell neoplasms 0.406391 Children's Cancer 0.42175 cell tumors show 0.406094 pediatric germ 0.426106 adultos jóvenes 0.40725	estadio iv 0.405826 ganglios linfáticos ≥2 0.411723 Germ Cell Consensus 0.412507 Cushing B 0.405386 teratomas benignos 0.407141 Genes Chromosomes Cancer 0.438953 with germ 0.406335 malignant germ cell 0.462527 PDQ Tratamiento 0.405882 childhood germ 0.409831 cell tumors based 0.405903 Clin Oncol 0.444548 saco vitelino 0.435575 linfáticos ≥2 cm 0.408554 Schneider DT 0.409517 Children's Cancer Group 0.419331 Cell Consensus Classification 0.409901 germ cell tumors 0.974328 Kingdom Children Cancer 0.408316 germ cell cancer 0.410294 Children's Cancer Study 0.409136 pediatric oncology group 0.410202 oncology group 0.420408 Cancer Study Group 0.411644	CLICK HERE
1908	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	linfocítica aguda 0.505572 leucemia promielocítica aguda 0.536157 siguientes procedimientos 0.505247 células madre 0.703397 leucemia mielógena aguda 0.512482 posibles factores 0.501447 siguientes aspectos 0.5019 leucemia aguda 0.511873 radiación quizás 0.505162 leucemia linfoblástica aguda 0.535526 LMA quizás 0.505703 hueso compacto 0.505434 neoplasias mieloides 0.501631 rayos x 0.501258 enlace drugs approved 0.505977 Acute Myeloid Leukemia 0.506164 célula madre mieloide 0.516071 cáncer.ampliar aspiración 0.501565 líquido cefalorraquídeo 0.511938	punción espinal.Ampliar 0.501523 National Cancer Institute 0.501258 leucemia granulocítica aguda 0.512402 Instituto Nacional 0.502137 célula madre linfoide 0.510737 PDQ Tratamiento 0.503456 sustancia química benceno 0.502803 leucemia mielógena 0.513696 médula espinal.ampliar quimioterapia 0.50588 leucemia mieloblástica aguda 0.512403 sistema nervioso central 0.50789 Physician Data Query 0.504454 madre mieloides 0.518606 siguientes situaciones 0.504197 células madre mieloides 0.508803 leucemia mieloide aguda 0.995372 célula madre 0.532153 blastocito mieloide 0.505386 siguientes sumarios 0.503116	CLICK HERE
2987	National Cancer Institute	Html	en	Secondhand Smoke	When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
15609	National Cancer Institute	Html	es	Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.	problemas pasajeros 0.409161 lesiones benignas 0.409862 piel vecina 0.430821 efectos secundarios meses 0.423036 importantes preguntas 0.409508 siguientes especialistas 0.418218 siguientes síndromes 0.413185 rayos x 0.412063 niño ayuda 0.413721 escamas llamadas placas 0.409897 tumores benignos 0.516528 tumor vascular benigno 0.534618 Instituto Nacional 0.412348 alta potencia 0.411312 células llamadas 0.410367 tumores vasculares benignos 0.9178 venas sanas vecinas 0.421159 nuevos tipos 0.412108 sangre circula 0.414383 medicamentos propranolol hydrochloride 0.437459 angiofibroma nasofaríngeo 0.468048 hemangioendotelioma epitelioides 0.436434 once tipos 0.436191 glándula tiroides 0.427118 posibles efectos tardíos 0.424225	adultos jóvenes 0.418525 siguientes tumores 0.604051 granulomas piógenos 0.445724 hemangioma capilar lobulillar 0.505924 siguientes tipos 0.41901 ondas sonoras 0.412577 efectos tardíos 0.50862 PDQ Efectos tardíos 0.43716 vías respiratorias 0.428225 tarde.ampliar ecografía 0.413763 granuloma piógeno 0.509033 IRMN).Ampliar Imágenes 0.410245 sección opciones 0.41178 hemangioendoteliomas epitelioides 0.418326 PDQ Tratamiento 0.421361 afección llamada esclerosis 0.414532 siguientes signos 0.417619 siguientes casos 0.414811 Physician Data Query 0.425443 propranolol iv 0.42341 insuficiencia cardíaca 0.475544 hemangioma epitelioide 0.568564 siguientes pruebas 0.434586 angiofibromas nasofaríngeos juveniles 0.440153	CLICK HERE
16681	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel Members	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.	Walton Endowed Chair 0.567818 Cancer Genome Computational 0.597352 National Cancer Advisory 0.650925 cancer advocacy groups 0.631303 Integrative Cancer Research 0.659981 Cancer Disparities Program 0.610947 C. Zamecnik Chair 0.57469 Senior Vice President 0.528963 Harvard Medical School 0.539573 Chief Executive Officer 0.838453 Moores Cancer Center 0.633784 Cancer Center 0.989395 Principal Deputy Director 0.559096 Kimmel Cancer Center 0.636717 MGH Cancer Center 0.643509 Associate Professor 0.561481 Texas MD Anderson 0.619653 Scott Cancer Center 0.628322 Hopkins University School 0.586476 Lurie Comprehensive Cancer 0.604578 National Brain Tumor 0.535602 Alumni Distinguished Professor 0.55884 cancer health disparities 0.665713 Thomas Jefferson University 0.541957 cancer prevention 0.57231	Lineberger Comprehensive Cancer 0.60209 Huntsman Cancer Institute 0.643082 Ph.D 0.602332 Anderson Cancer Center 0.720144 Dana-Farber Cancer Institute 0.630726 Louisiana State University 0.545794 Pfizer Worldwide Research 0.555824 National Cancer Institute 0.714187 Cancer Research 0.712054 Sidney Kimmel 0.530896 Hospital Cancer Center 0.648303 Blue Ribbon Panel 0.726957 M.D 0.540388 Executive Vice President 0.545293 MD Anderson Cancer 0.692003 Ludwig Cancer Research 0.634757 Clinical Cancer Care 0.584227 Comprehensive Cancer Center 0.832766 Clausen Distinguished Professor 0.578861 Cancer Survivorship 0.543835 Kimmel Comprehensive Cancer 0.643464 Vanderbilt-Ingram Cancer Center 0.63051 University Feinberg School 0.566744 Deputy Director 0.630447	CLICK HERE
16775	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.429084 New Hampshire Avenue 0.419912 cabo ensayos 0.419001 Drug Administration 0.412413 NCI Best Case 0.439351 tipo cancell 0.440349 mejores pruebas 0.415762 datos bibliográficos pubmed 0.42161 siguientes preguntas 0.412513 James V 0.418429 National Cancer Institute 0.425345 siguientes riesgos 0.416342 seguro médico 0.411884 Instituto Nacional 0.685274 vitamina e 0.418575 Salud Complementaria 0.444832	Visuals Online 0.415001 complementarias revisa 0.421711 Physician Data Query 0.488672 nombre cancell 0.440323 Estados Unidos 0.994944 libre uso 0.416016 suficiente actividad 0.418205 siguientes sustancias 0.422749 página manejo 0.413947 ¿El tratamiento 0.424367 ¿Los beneficios 0.412704 juntos cam 0.411781 Series Program 0.412549 medicina complementaria 0.882014 Institutos Nacionales 0.47694	CLICK HERE
16841	National Cancer Institute	Html	en	Nanotechnology Characterization Laboratory (NCL)	The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.	extensive educational outreach 0.634447 FDA 0.244496 Nanotechnology Characterization Laboratory 0.767048 oncology-directed therapies 0.46705 great strides 0.507003 pursuit 0.246467 death rate 0.462099 Drug Administration 0.456372 unique setup 0.432854 progression 0.249487 concert 0.241265 effort 0.242009 extraordinary opportunity 0.441323 dozen NCL collaborators 0.920466 disadvantages 0.25207 relatively limited time 0.630205 biocompatibility trends 0.467853 National Cancer Institute 0.664151 National Institute 0.449153 Food 0.241207	human clinical trials 0.632541 development 0.239992 clinical translation 0.459921 therapeutic outcomes 0.469235 diagnosis 0.245742 difficult diseases 0.491415 diagnostic capabilities 0.458058 novel nanomedicines 0.45591 vast array 0.436858 different nanomaterials 0.457741 Standards 0.240975 population 0.239972 diagnostics 0.244317 advantages 0.242363 cancers 0.321573 foremost nanotechnology research 0.719052 preclinical characterization 0.513184 novel treatment strategies 0.62837 incidence 0.254427 multi-disciplinary team 0.450189	CLICK HERE